Skip to main content

Table 5 Multivariate analysis for OS and PFS.

From: Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life

Overall Survival (OS)

P value

Tumour control (SD, CR, PR)

0.007

Brain progression (PD)

 

KPS <70

0.024

KPS ≥ 70

 

Age ≤ 65 years

0.792

Age > 65 years

 

RPA 1

0.004

RPA 2

 

RPA 3

 

Progression Free Survival (PFS)

P value

Tumor control (SD, CR, PR)

0.001

Brain progression (PD)

 

KPS <70

0.05

KPS ≥ 70

 

No extracranial disease

0.810

Extracranial disease

 

Age > 65 years

0.310

Age ≤ 65 years

 

RPA 1

0.001

RPA 2

 

RPA 3